FDA approves new leukemia drug.
Tasigna, known generically as nilotinib, won approval to treat chronic and accelerated phase Philadelphia chromosome-positive, chronic myeloid leukemia. The form of the blood cancer affects about 4,500 Americans a year.

I make sure to eat at least 1 fruit a day as a proactive measure.
Leave a comment: